NCT05789342View on ClinicalTrials.gov

A Study to Evaluate the Drug-drug Interactions (DDIs) of GP681 With Rosuvastatin, Digoxin, Itraconazole, Oseltamivir in Chinese Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

February 15, 2023

Primary Completion Date

September 11, 2023

Study Completion Date

October 31, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

GP681

GP681, tablet, oral

DRUG

Rosuvastatin

Rosuvastatin, tablet, oral

DRUG

Digoxin

Digoxin, tablet, oral

DRUG

Itraconazole

Itraconazole, capsule, oral

DRUG

Oseltamivir

Oseltamivir, capsule, oral

Trial Locations (1)

Unknown

China-Japan Friendship Hospital, Beijing

Sponsors
All Listed Sponsors
lead

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

INDUSTRY